Professor Sir David Lane is one of the scientists credited with the landmark discovery of cancer gene p53 in 1979. p53, called the "Guardian of the genome" is considered the most significant of all the genes altered in cancer cells because mutations of the gene are known to cause almost...

Current AppointmentsChairman, Council for Advanced Regenerative Medicine (CARM)Board Member, Korea Institute of S&T Evaluation and PlanningAuditor and Fellow, National Academy of Engineering of KoreaAdvisor, Bio Economy Committee, Government of MalaysiaAdvisor, Rice University Bioengineering...

Dr Carl Firth is the Founder and CEO of ASLAN pharmaceuticals, a Singapore company with offices in Taiwan and China, which is developing novel medicines for global markets in oncology and inflammation. Previously, Carl was the Head of Asia Healthcare at Bank of America Merril Lynch, supporting...

Dr. Tang has worked as a medical reviewer since 2010, firstly in the Taiwan Food and Drug Administration (TFDA) then in the Center for Drug Evaluation (CDE). TFDA is the competent authority in charge of food, drugs, controlled drugs, medical equipment and cosmetics related management in Taiwan; CDE ...

A Board certified Oncologist and Haematologist with over 30 years in basic science, academia and industry, as Principal Investigator, Institutional Research Head and Chief Medical Officer, overseeing basic and clinical research. He has been included in the conduct of over a 100 studies with a focus ...

Dr Ede has a record of successfully evolving research concepts to commercial products and processes. He has over 25 years experience in drug discovery and international business development gained at Chiron Corporation - now Novartis (VP Chemistry), EqiTX Ltd (COO), Mimotopes Pty Ltd (CEO), Adistem ...

Dr James Garner is CEO of Kazia Therapeutics Limited, an ASX- and NASDAQ-listed, oncology-focused biotech company, based in Sydney Australia. Kazia’s lead program, GDC-0084, was licensed from Genentech in October 2016, and is due to enter a phase II clinical trial in glioblastoma multiforme. A...

Kamal is a trained Chemist who decided to pursue a career in supply chain management and quality. In this role, he was tasked to supervise commercial and clinical trial products. Kamal has worked in the pharmaceutical and device industries for over 10 years in different size organisations ranging...

Dr Anand Gautam has 25 years of leadership in R&D and innovation strategies in Inflammation/Autoimmune Diseases/Cancer at international biotech and pharmaceutical companies. In addition, Anand has spent over 12 years as an academic in Immunology in prestigious research centers in the UK (PhD at ...

Mr. Vishal Doshi, B. Pharm, M.Sc.CEO and Founder of AUM Biosciences. A Pharmacist by training, he is an experienced senior management with extensive experience in clinical research related experience across the Pharmaceutical/CRO Industry. Mr. Doshi is a Key Opinion Leader with the Korean Health...

Dr. Seokjoong Kim is an experienced molecular biologist in the field of programmable nuclease development and genome editing technology. Following his Ph.D. studies in the laboratory of Prof. Thomas Boyer at University of Texas Health Science Center at San Antonio, Dr. Kim joined the group of...

Vicky Han, Senior Director, Group Lead for Regulatory Policy in Asia Pacific at Johnson & Johnson Pharmaceuticals, is currently in charge of Asia Pacific regulatory policy, in particular focusing on China and Japan, while engaging with external stakeholders for improving the regulatory...

Dr Jeonghoon Han is Vice President, CDO and CFO of Medicine Development Division & Management Planning Division at Eutilex, an innovative immuno-oncology biotech company based in South Korea. He is responsible for Eutilex pipeline development, global regulatory approval and global marketing and ...

Hironoshin Nomura is a member of Mizuho’s industry-leading Japan Health Care team, and is Mizuho’s lead analyst for Japanese biotech. In that role, he has met with all 44 of Japan’s publicly listed biotech companies, and publishes official research reports (including investment ratings and price...

Mario Bertazzoli is a physician and a registered specialist in Human Reproduction Pathology. He received both medical and specialization degrees from the University of Milan, Italy and worked as physician at the Obstetric and Gynaecological Department, University of Milan, and for the Italian...

Liping Liu is the founder, CEO & CSO of HighTide Therapeutics, a globally focused company to develop therapeutics for chronic non-viral liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied markets needs. The company’s lead drug is a first-in-class new...

With more than 18 years of experience in clinical research & operations, Maggie has spent most of her time in R&D early phase clinical development, led regional training for 5 years  before moving onto Clinical Development Quality Assurance within GSK R&D for the last  4 years. She has...

Chongdeok Park joined KOLON Pharma, one of leading Korea based Pharmaceutical companies and is responsible for development in R&D, including portfolio management, external R&D Collaboration, medical affairs, regulatory affairs, market access and business development.  Prior to Kolon...

When Edmund’s younger son Branden was diagnosed with spinal muscular atrophy (SMA), he was told to prepare for the worst. There was no cure for SMA which is the No.1 genetic killer of young children. There was no giving up, and Edmund desires to give his family every chance to live an...

Financially independent since age 13 (1997), Wharton graduate (2009), lived and worked in the US, China and Singapore, plus extensive operating and investment experience in Europe. Transformed Esco into a global life science and medical equipment manufacturer and solutions provider, growing...

Life sciences and digital health investor with systems-based perspective presently preparing for launch of inaugural fund. Prior to this led life sciences and digital health practice for Oliver Wyman in Asia, co-founded medical device company in real-time brain imaging, and worked at a...

Charles has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He now leverages this breadth of experience in leading Accera in the fight against Alzheimer's and other neurological diseases.Prior to joining Accera, Charles was with Inventages, a global...

Sabrina Ng is the Chief Financial Officer of Hummingbird Bioscience where she is responsible for overseeing most Business Support functions including Finance, Human Resources, Operations and Fund-raising.  She has led Hummingbird’s various fund-raising rounds, including dilutive and non-dilutive...

Charles Dwo Yuan SIA is the Chief Technology Officer of BravoVax. He was an Investigator (Professor) of National Institute of Infectious Diseases and Vaccinology at National Health Research Institutes, Taiwan. Prior of joining NHRI, he was the Director of Immunology and Vaccinology in UBI (USA)...

Dr. Lietao Li is the co-founder, chairman of the board, and CEO of Lion TCR Pte. Ltd.  Dr. Li has over 20 years of biopharmaceutical industrial experience and 4 years of clinical experience. Dr. Li founded his first biotech company specializing in vaccine development, where he served as the...

Gopal Rao is part of the Global BD and Licensing team at Lupin Biotech based out of the Biotech Division of Lupin at Pune, India, responsible for product evaluation, commercial launch strategy, Evaluating and finalizing B2B licensing partners in Japan and Emerging markets along with liaising with...

Yongho Oh, MPH, PMP, is the Regional Clinical Project Manager & ISS Project Manager for Asia, JPAC and China region in Sanofi. With over a decade of experience, Yongho oversees the project management activities related to various clinical trials, epidemiology and pharmaco-epidemiology...

Gavin Teo is a General Partner at B Capital Group, a US and Singapore-based VC firm, where he leads the firm’s healthcare investments and heads the San Francisco office. Mr. Teo serves as a Board Director for AIMotive, Atomwise, Bright.md, Fishbrain and SilverCloud Health and co-manages the firm’s...

Hsiao-Hui Tsou (Sophie) received her Ph.D. in Mathematical Statistics from the University of Maryland, College Park, in 2005. She did her post-doctoral training in Division of Biostatistics and Bioinformatics, National Health Research Institutes, Taiwan (2005-2008). She was reappointment to be an...

During the previous stints with pharmaceutical and ITES/CRO organizations, Mrunalini has exhibited expertise in steering global clinical data management projects conducted across US, EU & APAC to successful completion. Currently, she is associated with SICS A*STAR where she is leading data...

Dr Yeo Jing Ping is the Director for Research Integrity, Compliance and Ethics in Singapore Health Services Pte Ltd.  In her role in the institution, she leads a team that is responsible for ensuring proper oversight of research quality, integrity and compliance.She has more than 20 years of...

Arani Chatterjee, MBBS, MPhil, PGCPM completed his graduation from CMC, Vellore and post-graduation from NIMHANS, Bangalore. He has a Post Graduate Certificate in Management from IIM, Indore. Before joining Aurobindo Pharma, he was Senior Vice President, Clinical Research at Biological E, Hyderabad ...

Dr Tan is the founding director of Northeast Medical Group. After graduating from University of Melbourne in 1995, he obtained postgraduate qualifications in Dermatology, Occupational Medicine and in Public Health. Alongside clinical work, he oversees a group of medical clinics, a specialist centre ...

Dr. Sean Cao is currently the Managing Director of C-Bridge Capital, a health care Private Equity fund based in China, and the President and interim CEO of Everest Medicines, a biopharma company focused on developing innovative therapeutics in China. Prior to that, Dr. Cao was VP of Global Business ...

Md. Salahuddin was born in chaipainawabganj, Bangladesh on 1st June, 1965. He got M.SC in Biochemistry from Rajshahi University, Bangladesh in 1990. He worked about four years in Pharmaceuticals Industry and joined in Directorate General of Drug Administration on March 27, 1994 as Superintendent of ...

Sinclair is a Founder and Managing Partner at Epidarex Capital, an international life science and health technology venture fund based in Edinburgh, UK and Bethesda, MD.  Epidarex funds the commercialisation of ground-breaking research and new technologies to address unmet needs in today’s...

•    A medical oncologist, with a broad and deep range of experience in pharmaceutical industry for both clinical development and medical affairs in oncology area. Lead regional team of clinical and medical affairs for cancer immunotherapy working with 14 countries across Asia Pacific•    A...

Yuliana currently serves as the President Director of PT Kalbe Genexine Biologics that focusing in product acquisition of early phase , clinical trial design, technology transfer in manufacturing, quality assurance and regulatory compliance. Prior to the current position, she held various position...

Henry Ines is the CEO of Shivom, a technology startup focused on developing the world's largest genomics datahub and healthcare services platform. Leveraging latest advancements in science and technology, including blockchain and AI, Shivom empowers its users to more securely store, share and...

Lynne has over 17 years’ experience in academic science and clinical research.  Following completion of her PhD from King’s College London, her career in clinical research started in the UK working as a clinical research associate for two global CROs before moving into clinical science at Pfizer. ...

Dr. Antonio Lee is the Global Head of Business Development at MEDIPOST (KOSDAQ: 078160; Seoul, Korea) and also serves as the CEO and Managing Director at MEDIPOST America Inc., a wholly-owned U.S. subsidiary of MEDIPOST.Since 2011, Dr. Lee has been involved in the global commercialization and...

A serial entrepreneur from Silicon Valley who successfully grew and sold his previous two ventures to Nokia and Citrix. He earned Computer Engineering degrees from Purdue University, and the University of Southern California. He was recently the CEO of women’s healthcare company, Celes Care (before ...

With more than 10 years of experience in clinical research at academia, pharmaceutical and biotech companies, Pei Yin is currently heading the Asia Clinical Operations Group based in the Singapore regional office within Eisai, a global pharmaceutical company. Since joining the company, she has...

Fiona Wong is currently overseeing clinical operation in Nutricia Research, focusing on operational excellence in studies conducted in Asia Pacific regions. Leveraging different scientific experts, she works strategically with cross-functional teams across Asia Pacific regions, the Netherlands and...

Jason believes in working towards a better world through data. A multi-disciplinary professional, he leads a high performing and quirky in-house data science team in MSD’s Global Data Science Competency where individuality is valued and nurtured. Jason and his team specialize in machine...

Dr. Bajpai is a physician, trained in Internal Medicine, Diabetes and Endocrinology with an experience of more than 25 years. He is currently the Global Medical Head for Disease Management and Stakeholder Engagement with Sanofi Emerging Markets Diabetes & CV, based in Singapore.His areas of...

Alexandre CIVIERE is the project manager for Cellprothera Pte Ltd. He graduated from Bordeaux University with a Master’s degree in Biomedical engineering and the University of Aix-en-Provence with an Msc in General Management. He is currently managing the ongoing clinical trial in...

Dr Wenzhi Tian is the founder and Chairman of ImmuneOnco Biopharma Co., Ltd, a start-up company in China, with primary focus of its R&D on tumor immunotherapeutic drugs including checkpoint modulators and target-activated NK (TANKTM) products that will meet the unmet medical needs both in China ...

Mr. Ian Huen is the Founder, Chief Executive Officer and Executive Director of Aptorum Group Limited. Mr. Huen is also the Executive Director and Co-Founder of a Hong Kong company, AENEAS CAPITAL LIMITED, a licensed corporation regulated by the Hong Kong Securities & Futures Commission as a...

Dr Hillyard is an experienced senior executive with a background in the life sciences industry. She is currently Deputy Chairman of the Mater Medical Research Institute. Prior roles include State and Federal government boards and committees, advising on biotechnology and venture capital. Dr...

12+ years experience in the Pharma Industry handling diverse therapeutic portfolios in Oncology, Cardiology, Thrombosis, Neuro-Psychiatry, Rheumatology, Gastroenterology, Immunology, Infectious diseases and Vaccines.

Nitin Jain serves as Vice President of Asia-Pacific at Ancillare, LP. Nitin’s focus is on driving operational excellence to support our client’s clinical and ancillary supply chain needs and oversee the complete end-to-end supply chain management operations of Ancillare’s Singapore Master...

Dr Anil Pareek is post graduate in Internal medicine form  Topiwala National Medical College and Nair Hospital Mumbai, and has also served as faculty in the same institute prior to joining Industry.He is presently working as President – Medical affairs and Clinical Research with Ipca laboratories...

Before founding Nextech Invest Ltd. in 1998, Scheidegger was managing director and member of the board of the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. Earlier he served as the first managing director of the Swiss Supercomputing Center (CSCS) and lead an international...

Ed Rosen is a serial entrepreneur with a foundation of success in multinational drug, device and diagnostic companies. Mr. Rosen is currently an Executive in Residence for the Technology Ventures Group at Columbia University and is the founder of Glendevon Life Sciences LLC. Ed was the founding...

Enver is currently the Country Manager for Pfizer Singapore and Vice President for Singapore Association of Pharmaceutical Industries (SAPI) and Chair of Public Policies Committee at SAPI. Enver joined Pfizer Singapore in September 2017 and prior to joining Pfizer Singapore, he has worked in Pfizer ...

As a medical physician with a degree in business, Susanne has been working for over 15 years in the healthcare and the pharmaceutical industries in various roles.In April 2018, Susanne took on the role as Global Head of Access to Medicines at Takeda and is leading Takeda’s strategy to enhance...

Former Vice President-Innovative Products Division of Xi’an Janssen Pharmaceutical, in charge of  business sales for Oncology & ImmunologyFormer Research Associate I/II at University of Michigan Cancer Center (Ann Arbor, MI, USA)Master of Business Administration from University of Michigan Ross ...

Dr. Gurel serves as Chief Scientific Officer for FRT – Field Robot Technology and holds an academic appointment as Visiting Professor at DGIST (Daegu Gyeongbuk Institute of Science & Technology), with previous positions at DGIST as Vice-Chair & Distinguished Invited Professor (Management of ...

Dr. Mai-Jing Liao is the Head of Business Development and Portfolio Management at Harbour BioMed (HBM). Prior to joining HBM, Dr. Liao was at Xian Janssen Pharmaceutical Ltd. where he served in multiple roles with increasing responsibilities in Marketing, Strategic Marketing and Business...

Stephanie Liu is a Senior Advisor of Clinical Quality Assurance Department at Lundbeck Singapore, who performs GCP/GLP/GVP audits in EU, Asia and US, she also hosts and coordinates authority inspections in the region.Stephanie studied at National Taiwan University with Major in Pharmacy. She...

Dr. Yi (Gloria) Wang is the Chief Medical Officer of TASLY Biopharmaceutical Co., Ltd. She has more than 15 years’ experience in clinical development for novel products including small chemical compound, monoclonal antibody, recombination protein and therapeutic cellular products such as CAR-T and...

Dr. Xichen Lin has been the Asia Pacific head of Search & Evaluation in Novo Nordisk since 2016.  In this role, he is responsible for identifying external innovation and driving maturation through collaboration with academic and biotech companies in China, South Korea, Japan, Australia and...